July 23 (Reuters) - Noxopharm Ltd NOX.AX :
* NOXOPHARM - CLAIMED BREAKTHROUGH IN SEARCH FOR RESTORING IMMUNE FUNCTION WITHIN "COLD" MICROTUMORS, CONVERTING THEM TO SO-CALLED "HOT" TUMORS
* NOXOPHARM LTD - DATA CONFIRMS IDRONOXIL AND VEYONDA, ACTIVATE CANCER-FIGHTING IMMUNE CELLS AND THEN ENABLE THEIR ENTRY INTO MICROTUMORS